Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Reasonable growth potential with adequate balance sheet.
Share Price & News
How has Agilent Technologies's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: A's share price has been volatile over the past 3 months.
7 Day Return
US Life Sciences
1 Year Return
US Life Sciences
Return vs Industry: A exceeded the US Life Sciences industry which returned 20% over the past year.
Return vs Market: A exceeded the US Market which returned 3.7% over the past year.
Price Volatility Vs. Market
How volatile is Agilent Technologies's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 days ago | Simply Wall StIs Agilent Technologies, Inc. (NYSE:A) Worth US$80.8 Based On Its Intrinsic Value?
4 weeks ago | Simply Wall StIs Weakness In Agilent Technologies, Inc. (NYSE:A) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
1 month ago | Simply Wall StHere's What Agilent Technologies, Inc.'s (NYSE:A) P/E Ratio Is Telling Us
Is Agilent Technologies undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: A ($84.98) is trading above our estimate of fair value ($64.16)
Significantly Below Fair Value: A is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: A is poor value based on its PE Ratio (38.6x) compared to the Life Sciences industry average (35.3x).
PE vs Market: A is poor value based on its PE Ratio (38.6x) compared to the US market (15.1x).
Price to Earnings Growth Ratio
PEG Ratio: A is poor value based on its PEG Ratio (1.7x)
Price to Book Ratio
PB vs Industry: A is good value based on its PB Ratio (5.5x) compared to the US Life Sciences industry average (5.6x).
How is Agilent Technologies forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A's forecast earnings growth (22.8% per year) is above the savings rate (2.2%).
Earnings vs Market: A's earnings (22.8% per year) are forecast to grow faster than the US market (21.6% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A's revenue (6.3% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: A's revenue (6.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A's Return on Equity is forecast to be high in 3 years time (20.5%)
How has Agilent Technologies performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A has high quality earnings.
Growing Profit Margin: A's current net profit margins (13%) are lower than last year (22.2%).
Past Earnings Growth Analysis
Earnings Trend: A's earnings have grown significantly by 20.2% per year over the past 5 years.
Accelerating Growth: A's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A had negative earnings growth (-38.8%) over the past year, making it difficult to compare to the Life Sciences industry average (10.6%).
Return on Equity
High ROE: A's Return on Equity (14.3%) is considered low.
How is Agilent Technologies's financial position?
Financial Position Analysis
Short Term Liabilities: A's short term assets ($3.2B) exceed its short term liabilities ($1.9B).
Long Term Liabilities: A's short term assets ($3.2B) exceed its long term liabilities ($2.7B).
Debt to Equity History and Analysis
Debt Level: A's debt to equity ratio (48.2%) is considered high.
Reducing Debt: A's debt to equity ratio has increased from 39.8% to 48.2% over the past 5 years.
Debt Coverage: A's debt is well covered by operating cash flow (35.3%).
Interest Coverage: A's interest payments on its debt are well covered by EBIT (15.7x coverage).
What is Agilent Technologies's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: A's dividend (0.85%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.75%).
High Dividend: A's dividend (0.85%) is low compared to the top 25% of dividend payers in the US market (4.73%).
Stability and Growth of Payments
Stable Dividend: A is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: A is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: A is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of A's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mike McMullen (58yo)
Mr. Michael R. McMullen, also known as Mike, has been the President of Agilent Technologies, Inc., since September 17, 2014 and Chief Executive Officer since March 18, 2015. Mr. McMullen has been a Directo ...
CEO Compensation Analysis
Compensation vs Market: Mike's total compensation ($USD12.52M) is about average for companies of similar size in the US market ($USD11.86M).
Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.
|CEO, President & Director||5.17yrs||US$12.52m||0.11% $29.9m|
|Senior VP & CFO||1.67yrs||US$4.38m||0.0020% $531.3k|
|Senior VP||4.33yrs||US$2.34m||0.012% $3.2m|
|Senior VP and President of Life Sciences & Applied Markets Group||no data||US$2.90m||0.036% $9.4m|
|Principal Accounting Officer||5yrs||no data||0.014% $3.7m|
|CTO & Senior VP||16.67yrs||no data||no data|
|Vice President of Investor Relations||no data||no data||no data|
|Senior Vice President of Human Resources||5.75yrs||US$2.21m||0.024% $6.4m|
|Senior Vice President of Global Infrastructure Services||no data||no data||no data|
|MD of UK & Ireland Operations and VP of Human Resources - Europe||15.33yrs||no data||no data|
Experienced Management: A's management team is seasoned and experienced (5.2 years average tenure).
|CEO, President & Director||5.17yrs||US$12.52m||0.11% $29.9m|
|Independent Director||20.25yrs||US$331.49k||0.0034% $882.1k|
|Independent Non-Executive Director||14yrs||US$356.49k||0.0015% $392.6k|
|Independent Director||9.33yrs||US$351.49k||0.0040% $1.1m|
|Independent Director||5.67yrs||US$331.49k||0.0047% $1.2m|
|Independent Director||2.17yrs||US$341.49k||0.0029% $753.8k|
|Independent Non-Executive Chairman||3.17yrs||US$486.49k||0.029% $7.5m|
|Independent Director||4.83yrs||US$341.49k||0.0084% $2.2m|
|Independent Director||2.83yrs||US$331.49k||0.0046% $1.2m|
|Independent Director||4.67yrs||US$341.49k||0.0064% $1.7m|
Experienced Board: A's board of directors are considered experienced (5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: A insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Agilent Technologies, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Agilent Technologies, Inc.
- Ticker: A
- Exchange: NYSE
- Founded: 1999
- Industry: Life Sciences Tools and Services
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$26.174b
- Shares outstanding: 308.00m
- Website: https://www.agilent.com
Number of Employees
- Agilent Technologies, Inc.
- 5301 Stevens Creek Boulevard
- Santa Clara
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|A||NYSE (New York Stock Exchange)||Yes||Common Stock||US||USD||Nov 1999|
|AG8||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Nov 1999|
|A *||BMV (Bolsa Mexicana de Valores)||Yes||Common Stock||MX||MXN||Nov 1999|
|0HAV||LSE (London Stock Exchange)||Yes||Common Stock||GB||USD||Nov 1999|
|AG8||ETLX (Eurotlx)||Yes||Common Stock||IT||EUR||Nov 1999|
|A1GI34||BOVESPA (Bolsa de Valores de Sao Paulo)||BDR EACH 2 REPR 1 SHS UNSPON||BR||BRL||Jan 2020|
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. The company was founded in 1999 and is headquartered in Santa Clara, California.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/05/26 01:21|
|End of Day Share Price||2020/05/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.